PL3006038T3 - Pojedyncze dawki orytawancyny do leczenia zakażenia bakteryjnego lub zapobiegania takiemu zakażeniu - Google Patents

Pojedyncze dawki orytawancyny do leczenia zakażenia bakteryjnego lub zapobiegania takiemu zakażeniu

Info

Publication number: PL3006038T3
Authority: PL; Poland
Prior art keywords: oritavancin; treating; preventing; bacterial infection; single doses
Prior art date: 2008-08-30

Application number

PL15195726.3T

Other languages

English (en)

Inventor

Dario Lehoux

Thomas Parr

Gregory Moeck

Pierre Etienne

Original Assignee

The Medicines Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-30

Filing date

2009-08-29

Publication date

2024-11-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3006038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-08-29 Application filed by The Medicines Company filed Critical The Medicines Company

2024-11-12 Publication of PL3006038T3 publication Critical patent/PL3006038T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

PL15195726.3T 2008-08-30 2009-08-29 Pojedyncze dawki orytawancyny do leczenia zakażenia bakteryjnego lub zapobiegania takiemu zakażeniu PL3006038T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9331408P	2008-08-30	2008-08-30
US9349708P	2008-09-02	2008-09-02

Publications (1)

Publication Number	Publication Date
PL3006038T3 true PL3006038T3 (pl)	2024-11-12

Family

ID=41722337

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL15195726.3T PL3006038T3 (pl)	2008-08-30	2009-08-29	Pojedyncze dawki orytawancyny do leczenia zakażenia bakteryjnego lub zapobiegania takiemu zakażeniu
PL09810708.9T PL2337575T3 (pl)	2008-08-30	2009-08-29	Sposoby leczenia z użyciem pojedynczych dawek orytawancyny

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL09810708.9T PL2337575T3 (pl)	2008-08-30	2009-08-29	Sposoby leczenia z użyciem pojedynczych dawek orytawancyny

Country Status (18)

Country	Link
US (2)	US8420592B2 (pl)
EP (3)	EP3006038B1 (pl)
JP (1)	JP5782615B2 (pl)
CN (2)	CN106620649A (pl)
AU (1)	AU2009285564B2 (pl)
CA (1)	CA2736860C (pl)
DK (2)	DK3006038T3 (pl)
EA (1)	EA020490B1 (pl)
ES (2)	ES2570401T3 (pl)
FI (1)	FI3006038T3 (pl)
HU (3)	HUE068423T2 (pl)
MX (1)	MX2011002249A (pl)
NL (1)	NL300834I2 (pl)
NO (1)	NO2016019I2 (pl)
NZ (1)	NZ591525A (pl)
PL (2)	PL3006038T3 (pl)
PT (1)	PT3006038T (pl)
WO (1)	WO2010025438A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI3006038T3 (fi) *	2008-08-30	2024-08-12	The Medicines Co	Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn
WO2010129233A2 (en)	2009-04-28	2010-11-11	Targanta Therapeutics Corp.	Methods of treating bacterial infections using oritavancin
WO2014031681A1 (en) *	2012-08-20	2014-02-27	The University Of Chicago	Inhibiting gram positive bacteria
WO2014176068A2 (en) *	2013-04-22	2014-10-30	The Medicines Company	Treatment and prevention of bacterial skin infections using oritavancin
ES2949169T3 (es) *	2013-08-26	2023-09-26	Melinta Therapeutics Inc	Procedimientos para tratar la bacteriemia y la osteomielitis utilizando oritavancina
EP3038615A4 (en) *	2013-08-28	2017-04-12	The Medicines Company	Methods for treating bacterial infections using oritavancin and polymyxins
US20170119793A1 (en) *	2014-06-12	2017-05-04	Cem-102 Pharmaceuticals, Inc.	Compositions and methods for treating bone and joint infections
EP3169345B1 (en) *	2014-07-17	2025-01-29	Melinta Therapeutics, LLC	High purity oritavancin and method of producing same
WO2017143169A1 (en) *	2016-02-18	2017-08-24	The Medicines Company	Oritavancin formulations
WO2017179003A1 (en)	2016-04-15	2017-10-19	Lupin Limited	Topical compositions for ophthalmic and otic use
CN108409837B (zh) *	2018-03-06	2021-09-24	上海来益生物药物研究开发中心有限责任公司	一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840684A (en)	1994-01-28	1998-11-24	Eli Lilly And Company	Glycopeptide antibiotic derivatives
US5994297A (en) *	1997-08-22	1999-11-30	Eli Lilly And Company	Therapy for Staphylococcus aureus
UA73937C2 (en) *	1999-05-03	2005-10-17	Lilly Co Eli	Method of treatment for long-term prevention of s. pneumoniae in susceptible individuals and pharmaceutical composition for realizing this method
US6858584B2 (en)	2000-05-02	2005-02-22	Theravance, Inc.	Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
US20030176327A1 (en) *	2001-10-25	2003-09-18	Cassell Gail Houston	Antibiotics for treating biohazardous bacterial agents
CA2487094A1 (en) *	2002-05-28	2003-12-11	Becton, Dickinson And Company	Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
US20040147441A1 (en) *	2002-08-23	2004-07-29	Leach Timothy S.	Methods and reagents for preventing bacteremias
US20040127403A1 (en) *	2002-09-06	2004-07-01	Francesco Parenti	Methods for treating and preventing Gram-positive bacteremias
US20070249577A1 (en) *	2005-05-10	2007-10-25	Hopkins Scott J	Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
EP2068890B1 (en) *	2006-09-25	2014-01-08	The Medicines Company	Use of oritavancin for prevention and treatment of anthrax
FI3006038T3 (fi) *	2008-08-30	2024-08-12	The Medicines Co	Oritavansiinin yksittäisannokset bakteeri-infektion hoitoon tai ehkäisyyn
WO2010129233A2 (en) *	2009-04-28	2010-11-11	Targanta Therapeutics Corp.	Methods of treating bacterial infections using oritavancin
EP3038615A4 (en) *	2013-08-28	2017-04-12	The Medicines Company	Methods for treating bacterial infections using oritavancin and polymyxins

2009
- 2009-08-29 FI FIEP15195726.3T patent/FI3006038T3/fi active
- 2009-08-29 HU HUE15195726A patent/HUE068423T2/hu unknown
- 2009-08-29 JP JP2011525264A patent/JP5782615B2/ja active Active
- 2009-08-29 US US13/060,811 patent/US8420592B2/en active Active
- 2009-08-29 ES ES09810708T patent/ES2570401T3/es active Active
- 2009-08-29 EA EA201100413A patent/EA020490B1/ru unknown
- 2009-08-29 CA CA2736860A patent/CA2736860C/en active Active
- 2009-08-29 PL PL15195726.3T patent/PL3006038T3/pl unknown
- 2009-08-29 MX MX2011002249A patent/MX2011002249A/es active IP Right Grant
- 2009-08-29 ES ES15195726T patent/ES2994966T3/es active Active
- 2009-08-29 DK DK15195726.3T patent/DK3006038T3/da active
- 2009-08-29 PL PL09810708.9T patent/PL2337575T3/pl unknown
- 2009-08-29 EP EP15195726.3A patent/EP3006038B1/en active Active
- 2009-08-29 DK DK09810708.9T patent/DK2337575T3/en active
- 2009-08-29 NZ NZ591525A patent/NZ591525A/en unknown
- 2009-08-29 WO PCT/US2009/055466 patent/WO2010025438A2/en not_active Ceased
- 2009-08-29 EP EP24186111.1A patent/EP4464375A3/en active Pending
- 2009-08-29 EP EP09810708.9A patent/EP2337575B1/en not_active Revoked
- 2009-08-29 PT PT151957263T patent/PT3006038T/pt unknown
- 2009-08-29 HU HUE09810708A patent/HUE027373T2/hu unknown
- 2009-08-29 AU AU2009285564A patent/AU2009285564B2/en active Active
- 2009-08-29 CN CN201610900690.5A patent/CN106620649A/zh active Pending
- 2009-08-29 CN CN2009801439475A patent/CN102215858A/zh active Pending
2013
- 2013-02-11 US US13/763,799 patent/US20130172237A1/en active Pending
2016
- 2016-10-06 HU HUS1600039C patent/HUS1600039I1/hu unknown
- 2016-10-11 NL NL300834C patent/NL300834I2/nl unknown
- 2016-10-11 NO NO2016019C patent/NO2016019I2/no unknown

Also Published As

Publication number	Publication date
NZ591525A (en)	2014-03-28
DK3006038T3 (da)	2024-08-26
EP3006038A1 (en)	2016-04-13
US20110201546A1 (en)	2011-08-18
NL300834I2 (pl)	2016-11-16
CA2736860A1 (en)	2010-03-04
PT3006038T (pt)	2024-08-23
HUE027373T2 (hu)	2016-09-28
NO2016019I2 (no)	2019-01-25
EP4464375A3 (en)	2025-02-26
CA2736860C (en)	2020-04-28
DK2337575T3 (en)	2016-05-23
CN106620649A (zh)	2017-05-10
ES2994966T3 (en)	2025-02-04
CN102215858A (zh)	2011-10-12
FI3006038T3 (fi)	2024-08-12
US8420592B2 (en)	2013-04-16
EA201100413A1 (ru)	2012-01-30
NO2016019I1 (no)	2016-10-11
HUS1600039I1 (hu)	2016-11-28
MX2011002249A (es)	2011-06-24
PL2337575T3 (pl)	2016-09-30
HUE068423T2 (hu)	2024-12-28
JP2012501349A (ja)	2012-01-19
EP3006038B1 (en)	2024-07-03
US20130172237A1 (en)	2013-07-04
WO2010025438A2 (en)	2010-03-04
AU2009285564A1 (en)	2010-03-04
EP2337575A4 (en)	2012-10-17
ES2570401T3 (es)	2016-05-18
EP2337575B1 (en)	2016-04-13
EP2337575A1 (en)	2011-06-29
EA020490B1 (ru)	2014-11-28
AU2009285564B2 (en)	2014-05-22
JP5782615B2 (ja)	2015-09-24
EP4464375A2 (en)	2024-11-20
WO2010025438A9 (en)	2010-05-14

Publication	Publication Date	Title
PL3006038T3 (pl)	2024-11-12	Pojedyncze dawki orytawancyny do leczenia zakażenia bakteryjnego lub zapobiegania takiemu zakażeniu
PL2326287T3 (pl)	2017-03-31	Modułowe urządzenie rozprzestrzeniające do leczenia protetycznych zakażeń stawów
ZA200906349B (en)	2010-06-30	Combination medicaments for treating bacterial infections
ZA201200899B (en)	2012-10-31	Composition for treating hbv infection
IL219321A0 (en)	2012-06-28	Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
EP2273989A4 (en)	2013-05-01	POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
ZA201300992B (en)	2014-07-30	Combination therapy for treating hcv infection
ZA201100616B (en)	2011-10-26	Treatment of antibiotic-resistant bacteria infection
ZA201008192B (en)	2011-08-31	A phytosystem for treatment of sewage
PL2424559T3 (pl)	2024-07-29	Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny
GB0918841D0 (en)	2009-12-09	Fibres for infection control
ZA201104669B (en)	2018-11-28	Implantable devices for treating hiv
IL205035A0 (en)	2010-11-30	Methods of inhibiting viral infection
IL204940A0 (en)	2010-11-30	Methods of inhibiting viral infection
GB0815179D0 (en)	2008-09-24	Medication and treatment for infection
GB0807781D0 (en)	2008-06-04	Treatment of bacterial infection
HK1171668A (en)	2013-04-05	Composition for treating hbv infection
AU2012202689B2 (en)	2012-11-22	dsRNA for treating viral infection
AU2009900969A0 (en)	2009-03-26	Treatment of infection
HK1162969A (en)	2012-09-07	Cyclosporin analogues for preventing or treating hepatitis c infection
ZA201104003B (en)	2013-05-29	Drug for treating infections
PL2194984T3 (pl)	2013-08-30	Lek do leczenia lub zapobiegania proteinurii
HK1179473A (en)	2013-10-04	Methods for treating infection
ZA200802123B (en)	2009-02-25	Benzodiazepine derivatives for treating hepatitis C infection
AU2010901811A0 (en)	2010-05-13	Avian-Based Treatment for Microbial Infection